Related Experiment Videos
Automated prostate volume determination with ultrasonographic imaging
R G Aarnink1, A L Huynen, R J Giesen
1Department of Urology, University Hospital Nijmegen, The Netherlands.
The Journal of Urology
|May 1, 1995
Summary
Automated prostate volume measurement using ultrasonography offers an objective alternative to manual methods. This new technique provides accurate results for benign prostatic hyperplasia treatment follow-up and prostate specific antigen density calculations.
Area of Science:
- Urology
- Medical Imaging
- Computational Biology
Background:
- Prostate volume measurement is crucial for diagnosing and managing benign prostatic hyperplasia (BPH).
- Current ultrasonography methods for prostate volume assessment are subjective and prone to inter-observer variability.
- Objective and reproducible methods are needed for accurate BPH treatment monitoring and multicenter trial comparisons.
Purpose of the Study:
- To develop and validate an automated method for prostate volume determination using ultrasonography.
- To overcome the subjectivity inherent in manual planimetric volumetry.
- To assess the accuracy and reliability of the automated method compared to reference measurements.
Main Methods:
- Development of an automated prostate volume measurement technique based on planimetric volumetry.
- Application of an edge detection algorithm to identify prostate boundaries in sequential ultrasonographic images.
- Validation of the automated method in a cohort of 55 patients, comparing results to reference prostate volume measurements.
Main Results:
- The automated method demonstrated a high correlation with reference prostate volume measurements (Pearson correlation coefficient = 0.93).
- The estimated ratio of automated to reference volume was 0.92, indicating good agreement.
- The method successfully overcame individual subjectivity in interpreting ultrasonographic images.
Conclusions:
- The developed automated method provides accurate and objective prostate volume measurements.
- This technique is valuable for monitoring benign prostatic hyperplasia treatments and for multicenter clinical trials.
- The automated method facilitates objective prostate specific antigen density (PSAD) determination.